VARIANTS OF CLINICAL COURSE AND METHODS OF TREATMENT OF VIRAL HEPATITIS DELTA

Article Sidebar

PDF
Published: 2025-12-05
DOI: https://doi.org/10.66073/ReFocus-Conf/413
Keywords:
hepatitis D virus, RNA test, intoxication, splenomegaly, jaundice, arthralgia

Main Article Content

Bakhronov Jakhongir Jasurovich
Assistant Professor, Department of Infectious Diseases, Samarkand State Medical University
Kholmuminov Azizjon Abror ugli
Master of Science in the Department of Infectious Diseases, Samarkand State Medical University

Abstract

Hepatitis D is an inflammation of the liver caused by the hepatitis D virus (HDV), which
requires hepatitis B virus (HBV) for its replication. Hepatitis D infection cannot occur in the absence of
HBV. HDV–HBV co-infection is considered the most severe form of chronic viral hepatitis due to more
rapid progression towards hepatocellular carcinoma and liver-related death. Vaccination against hepatitis
B can prevent HDV infection. HDV has recently been classified as carcinogenic to humans (class I) by the
IARC mongraph programme, just like hepatitis B and C. 

Article Details

Issue

Vol. 1 No. 1 (2025): Republican scientific-practical conference on “New Paradigms in Science, Technology and Education”

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Bakhronov Jakhongir Jasurovich, & Kholmuminov Azizjon Abror ugli. (2025). VARIANTS OF CLINICAL COURSE AND METHODS OF TREATMENT OF VIRAL HEPATITIS DELTA. Partner Conferences of the International Scientific Journal Research Focus, 1(1), 512-516. https://doi.org/10.66073/ReFocus-Conf/413

References

1. Nwokediuko S.C., Ijeoma U. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. Niger J Clin Pract 2009;12(4):439-42. 41. Rehak V. Устное выступление на моноконференции EASL "Гепатит дельта", Стамбул, Турция, 24-26.09.2010.

2. Rizaev J.A., Rizaev E.A., Akhmadaliev N.N. Current View of the Problem: A New Approach to Covid-19 Treatment // Indian Journal of Forensic Medicine & Toxicology, 2020. Т. 14. № 4.

3. Bakhronov J.J. ETIOLOGY, EPIDEMIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS B // Экономика и социум. 2025. №8 (135). URL: https://cyberleninka.ru/article/n/etiology-epidemiologyand-pathogenesis-of-viral-hepatitis-b (дата обращения: 10.11.2025).

4. Bakhronov J. J. ETIOLOGY, EPIDEMIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS DELTA // Экономика и социум. 2025. №6-2 (133). URL: https://cyberleninka.ru/article/n/etiologyepidemiology-and-pathogenesis-of-viral-hepatitis-delta (дата обращения: 10.11.2025).

5. Nematov H. A., Bakhronov J. J. CYTOMEGALOVIRUS INFECTION //Web of Medicine: Journal of Medicine, Practice and Nursing. – 2024. – Т. 2. – №. 12. – С. 335-344.

6. Zhasurovich B. Z. OCCULT HBV INFECTION //SHOKH LIBRARY. – 2025.

7. Zhasurovich B. Z. PREGNANCY AND VIRAL HEPATITIS B //SHOKH LIBRARY. – 2025.

8. Jakhongir B. et al. HEPATITIS C IN PREGNANT WOMEN AND NEWBORNS //Вестник магистратуры. – 2023. – №. 7 (142). – С. 10-12.

9. Rukhshonabonu M. et al. СLINICAL MANIFESTATION OF LENNOX-GASTAUT SYNDROME //Вестник магистратуры. – 2023. – №. 7 (142). – С. 19-21.

10. Bakhronov J. J. Kholmurodov Sh. F., Yakhyaeva Kh. D., Kuchkorov Sh. B. The role of artificial intelligence inmodern medicine //Innovations in Technology and Science Education. – 2024. – Т. 2. – №. 7. – С. 464-467.

11. Smedile A., Verme G., Cargnel A. et al. Influence of delta infection on severity of hepatitis B. Lancet 1982. - 320:945–947.

12. Wedemeyer H., Yurdaydin C., Dalekos G. et al. Peginterferon plus adefovir versus either drug alone for Hepatitis delta. N.Engl. J.Med., 2011. Vol. 364. P. 322–331.

13. Yarmukhamedova N.A. et al. Functional changes in the cardiovascular system in patients with chronic forms of brucellosis." //Achievements of science and education, 2020. № 4. С. 58.

14. Orzikulov Azam Orzikulovich, Khaidarov Akbar.Ne’matov H.A. Clinical features of the course of erysipelas of the skin at the present stage // Web of Medicine: Journal of Medicine, Practice and Nursing. – Vol. 2 No. 3 (2024): WOM. pp 95-100

15. Bakhronov , J. J., Otakulov , D. A. ugli, & Nigmatullaev , M. N. (2023). GILBERT’S SYNDROME: CURRENT INSIGHTS, OUTCOMES AND THERAPIES. GOLDEN BRAIN, 1(16), 131–

16. Ne’matov H.A.,Tirkashev O.S. Specific clinical and epidemiological features of scarlet fever // Web of Scientist: International Scientific Research Journal. – 2023. – No. 1 (4). pp. 578–584

17. Шарипова О.А., Бахронов Ш.С., Алиакбарова Х.И., Бахронов Ж.Ж. G3O8A полиморфизм гена tnf-a в развитии рецидивного бронхита у детей и его влияние на синтез tnf-a // Amaliy va tibbiyot fanlari ilmiy jurnali. – Vol. 3 No. 2 (2024): WOM. pp 269-275

18. Rakhmonov Ravshan Namozovich, Mansurov Jasur Choriyor ugli, Sobirov Og’abek Sobir ugli ugli, & Allanazarov Alisher Boymuratovich. (2024). Acute Obstructive Bronchitis in Children: Main Etiological and Clinical Features. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(2), 98–100.

19. Rakhmonov Ravshan Namozovich, Khalimov Farzod Zafar ugli, Usmonov İslombek Akbar ugli, & Kardzhavova Gulnoza Abilkasimovna. (2024). An Integrated Approach to the Treatment of CommunityAccompany Pneumonia in Children 2ith Myocarditis. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(2), 84–97.20. Ne’matov H.A., Bhavya Shah. Determination of the incident level of chronic viral hepatitis among the population of Oqdaryo district (Samarkand region) // Web of Medicine: Journal of Medicine, Practice and Nursing. –Vol. 2 No. 5 (2024): WOMpp 16-18